WESTLAKE VILLAGE BIOPARTNERS
Westlake Village BioPartners is a venture capital firm focused on incubating and building life sciences companies with entrepreneurs that have the potential to bring transformative therapies and technologies to patients. The Westlake model is built on the founding team’s unique experience in successfully identifying and developing breakthrough therapies and building organizations.
WESTLAKE VILLAGE BIOPARTNERS
Industry:
Business Development Financial Services Venture Capital
Founded:
2018-01-01
Status:
Active
Contact:
(888) 828-6713
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-06 | ArsenalBio | Westlake Village BioPartners investment in Series B - ArsenalBio | 220 M USD |
| 2022-08-25 | 3T Biosciences | Westlake Village BioPartners investment in Series A - 3T Biosciences | 40 M USD |
| 2022-05-23 | Sinogen Biopharma | Westlake Village BioPartners investment in Series A - Sinogen Biopharma | 10 M USD |
| 2022-03-30 | Neuron23 | Westlake Village BioPartners investment in Series C - Neuron23 | 100 M USD |
| 2022-02-16 | Electra Therapeutics | Westlake Village BioPartners investment in Series B - Electra Therapeutics | 84 M USD |
| 2022-02-16 | Star Therapeutics | Westlake Village BioPartners investment in Venture Round - Star Therapeutics | 100 M USD |
| 2022-01-26 | Kyverna Therapeutics | Westlake Village BioPartners investment in Series B - Kyverna Therapeutics | 85 M USD |
| 2021-11-16 | ACELYRIN | Westlake Village BioPartners investment in Series B - ACELYRIN | 250 M USD |
| 2021-11-15 | Recludix Pharma | Westlake Village BioPartners investment in Series A - Recludix Pharma | 60 M USD |
| 2021-09-29 | Expansion Therapeutics | Westlake Village BioPartners investment in Series B - Expansion Therapeutics | 80 M USD |
More informations about "Westlake Village BioPartners"
Westlake Village BioPartners - Crunchbase
Westlake Village BioPartners is a venture capital firm focused on incubating and building life sciences companies with entrepreneurs that have the potential to bring transformative therapies and technologies to patients. The Westlake …See details»
Our People | Biotech Investors - Westlake Village …
People are every organization’s first and most valuable asset. Westlake BioPartners is a tightly-woven team of investment, scientific, and operational experts who get hands on alongside entrepreneurs to navigate trials and …See details»
Our Portfolio | Startup Biotech Companies - Westlake Village …
At Westlake BioPartners, we’re committed to empowering the founders and their companies that are discovering and developing the most promising new medicines. Building on these trusted …See details»
Westlake BioPartners® - LinkedIn
Westlake BioPartners® | 4,342 followers on LinkedIn. Westlake BioPartners is a people-first life science VC firm that crafts companies around world-class entrepreneurs. | It takes a village to ...See details»
Westlake Village BioPartners - Investments, Portfolio & Company …
Westlake Village BioPartners has made 3 diversity investments. Their most recent diversity investment was on Aug 25, 2022, when 3T Biosciences raised. obfuscated. obfuscated. …See details»
Westlake Biopartners Overview - Capital AUM
Westlake Biopartners 3075 Townsgate Road Westlake Village, CA 91361 Firm Size. Assets Under Management (AUM): $1.5 Billion; Number of Funds: 4; Employees: Firm Type: Venture …See details»
Founding Funders: Westlake Village Biopartners - Inside The Valley ...
May 17, 2024 Westlake Village BioPartners brought money to a biotech capital drought in 2018, debuting with a $320 million fund to stake a claim in a region overflowing with lab real estate …See details»
Westlake Village BioPartners Launches $450 Million Fund and …
Jul 18, 2023 Westlake Village BioPartners ("Westlake") today announced the launch of its third fund of $450 million to incubate and grow early stage next-generation biotechnology …See details»
Westlake Village BioPartners Launches $450 Million …
Jul 17, 2023 Westlake Village BioPartners is a Los Angeles area-based venture capital firm focused on incubating and building life sciences companies with entrepreneurs who have the potential to bring ...See details»
About Westlake | Life Science Venture Capital Firm
Westlake BioPartners is a life science venture capital firm where every aspect of our approach is founded on the understanding that people are paramount to success. We empower …See details»
Harper, Seidenberg's Westlake Village BioPartners reels in $500M …
Dec 15, 2020 Since unveiling Westlake Village BioPartners with a $320 million fund, the duo has invested in or incubated 11 companies, more than half of which are in the Los Angeles area. …See details»
Westlake Village BioPartners collects $450m for third fund
Jul 18, 2023 Westlake Village BioPartners has raised $450 million for its third fund to incubate and build-early-stage, next-generation biotechnology companies in the Los Angeles region …See details»
Latigo Biotherapeutics Debuts with $135 Million Series A …
Feb 14, 2024 Westlake Village BioPartners (“Westlake”) incubated the company. Westlake led the Series A financing with 5AM Ventures and Foresite Capital as co-leads with participation …See details»
VC launches biotech fund with $450M and 'recipe for success'
Jul 17, 2023 Westlake Village BioPartners has launched its third fund, a $450 million vault for developing early-stage, next-gen biotechs in Los Angeles and beyond.. The oversubscribed …See details»
Westlake Village BioPartners Launches $450 Million Fund and …
Jul 17, 2023 Westlake today announced the launch of its third fund of $450 million to incubate and grow early stage next-generation biotechnology companies in the Los Angeles region and …See details»
Westlake Village BioPartners Raises $500 Million for Biotech …
Dec 15, 2020 Life-sciences venture firm Westlake Village BioPartners has raised $500 million across two new funds after quickly deploying its $327 million debut investment pool launched …See details»
Latigo launches with $135 million for Vertex-competing pain drug
Feb 14, 2024 A fter three years being incubated by California VC Westlake Village BioPartners, a new biotech launched Wednesday with $135 million and plans to compete with Vertex …See details»
Westlake Village BioPartners Launches Two New Funds Totaling …
LOS ANGELES, Dec. 15, 2020 /PRNewswire/ -- Westlake Village BioPartners today announced the launch of two new funds totaling $500 million to build and invest in promising life sciences …See details»
News | Westlake BioPartners - Westlake Village Biopartners
Nov 19, 2024 NEU-411, a brain-penetrant, potent and selective kinase inhibitor, has potential to...See details»